The anti-inflammatory effects and improvement of insulin resistance in the treatment with Sitagliptin and Berberine-induced synergistic pathways may modulate hepatic transaminases (ALT AST), increase adiponectin, and reduce TNFα. The gene discussed is GPT; the disease is Insulin resistance.